INVESTIGATIONS INTO THE ETIOLOGY OF DERMATITIS HERPETIFORMIS. II. THE EFFECTS OF SERUM FROM DERMATITIS HERPETIFORMIS CASES AND OF CERTAIN DRUGS ON THE VISCOSITY REDUCTION PROPERTY OF HYALURONIDASE.
D001152:Arsenicals; D001769:Blood; D001809:Blood Viscosity; D003622:Dapsone; D003874:Dermatitis Herpetiformis; D006493:Heparin; D006801:Humans; D006821:Hyaluronoglucosaminidase; D006854:Hydrocortisone; D010600:Pharmacology; D011193:Potassium Iodide; D011398:Promethazine; D014783:Viscosity
D001152:Arsenicals; D011193:Potassium Iodide; D003622:Dapsone; D006493:Heparin; D006821:Hyaluronoglucosaminidase; D011398:Promethazine; D006854:Hydrocortisone
ARSENICALS; BLOOD; BLOOD VISCOSITY; DAPSONE; DERMATITIS HERPETIFORMIS; HEPARIN; HYALURONIDASE; HYDROCORTISONE; PHARMACOLOGY; POTASSIUM IODIDE; PROMETHAZINE